Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,747.50
Bid: 1,747.00
Ask: 1,747.50
Change: 14.00 (0.81%)
Spread: 0.50 (0.029%)
Open: 1,736.00
High: 1,750.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

9 Oct 2019 10:21

UPDATE 1-British blue-chips trail Europe as Brexit deal hopes lift pound

* FTSE 100 up 0.1%, FTSE 250 down 0.1%* GVC gains after forecast upgrade* Just Eat tops blue-chip risersBy Muvija M and Shashwat AwasthiOct 9 (Reuters) - London's exporter-laden FTSE 100 lagged its European peers on Wednesday, as sterling gained on ...

Read more
8 Oct 2019 16:53

UPDATE 3-GSK recalls popular heartburn drug Zantac globally after cancer scare

* GSK recalls Zantac products in all markets as a "precaution"* Four products recalled; OTC ones not affected -UK regulator* GSK says working with regulators to address concerns (Tweaks headline, first paragraph; adds company comment)By Justin Geo...

Read more
8 Oct 2019 16:53

UPDATE 2-GSK recalls prescription-only versions of heartburn drug Zantac

* Four products recalled; over-the-counter ones not affected* UK regulator says recall a "precautionary measure"* Regulators investigating ranitidine drugs for impurities (Adds details on products affected, context on other drugmakers halting suppl...

Read more
8 Oct 2019 16:53

UPDATE 1-GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

(Adds context on U.S. FDA move)Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.The mo...

Read more
8 Oct 2019 16:33

Drug Alert As GlazoSmithKline Recalls Zantac; Collaboration Launched

Drug Alert As GlazoSmithKline Recalls Zantac; Collaboration Launched

Read more
8 Oct 2019 16:25

GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.GSK is recalling all unexpired stock ...

Read more
7 Oct 2019 09:29

UPDATE 2-Trade hopes lift FTSE 100, SIG drags down mid-caps

* FTSE 100 up 0.6%, FTSE 250 dips 0.3%* Hopes for U.S.-China deal help blue-chips* Mid-cap SIG plummets after profit warning (Adds company news items, updates share moves)By Muvija M and Shashwat AwasthiOct 7 (Reuters) - Oil majors led a rebound in ...

Read more
4 Oct 2019 17:31

UPDATE 1-Vectura, Sandoz win ruling on inhaler packaging case against GSK

(Adds comment from GSK spokesman)Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its favour on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.Vectura said the court dismissed all G...

Read more
4 Oct 2019 14:24

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

Read more
4 Oct 2019 08:06

FDA green lights AstraZeneca's asthma drug Fasenra for self-administration

Oct 4 (Reuters) - British drugmaker AstraZeneca said on Friday that the U.S. Food and Drug Administration (FDA) has approved self-administration of its asthma treatment Fasenra which uses a pre-filled, single-use auto-injector pen.The move is a bo...

Read more
3 Oct 2019 16:04

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
1 Oct 2019 07:43

UPDATE 1-AstraZeneca's combo lung disease therapy fails to win FDA approval

(Adds details on treatment, context and background)Oct 1 (Reuters) - The U.S. Food and Drug Administration declined to approve AstraZeneca Plc's combination therapy to treat smoker's lung, the drugmaker said on Tuesday.AstraZeneca said that it will...

Read more
30 Sep 2019 17:01

LIVE MARKETS-Europe ends another positive quarter on a high

* European end higher after choppy, low-volumes session * STOXX 600 +3.6% in Sept, marks 3rd positive quarter in a row * JPM raises euro-zone stocks to "overweight" * ECB's Draghi emphasises need for fiscal push - FT * Wall St...

Read more
30 Sep 2019 15:30

AstraZeneca strengthens Lynparza push with prostate cancer data

By Ludwig BurgerBARCELONA, Sept 30 (Reuters) - AstraZeneca presented results on Monday for a trial of its Lynparza drug against prostate cancer, which it hopes could lead to wider regulatory approval for the treatment for use against more forms of...

Read more
30 Sep 2019 14:48

LIVE MARKETS-An uneasy feeling of deja vu

* European shares tread water * STOXX 600 up 0.2% after slightly negative start * Volumes below average * JPM raises euro-zone stocks to "overweight" * ECB's Draghi emphasises need for fiscal push * Wall Street opens high...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.